Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®
Go back to Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 206.28 -0.35 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $206.63 | 52 Week High | $333.65 | |||
| Open | $208.75 | 52 Week Low | $223.02 | |||
| Day High | $209.03 | P/E | 26.41 | |||
| Day Low | $202.03 | EPS | $7.81 | |||
| Volume | 892,992 | |||||

